1
1) Slominski, A. T. et al. Adv Anat Embryol Cell Biol 212, 1–115 (2012).
2) Slominski, A. T. et al. Physiol Rev 84(4), 1155–1228 (2004).
3) 2017 年 美白スキンケアの市場分析調査.株式会社総合企画センター大阪.
4) Seiji, M, et al. J Invest Dermatol. 36, 243 (1961)
5) Kendric CS. Photochemical and Photobiologial Reviews, 3, 11 (1978)
6) d’Ischia M, et al. Pigment Cell Melanoma Res 2013; 26:616-633
7) Imokawa G, et al. J Biol Chem. 267, 24675-24680 (1992)
8) Kang HY, et al. Br J Dermatol. 154, 1094–1099 (2006)
9) Salducci M, et al. Pigment Cell Melanoma Res. 27, 502–504 (2014)
10) Hesegawa K, et al. Ann Dermatol. 27, 626–629 (2015)
11) Hirobe T, et al. J Dermatol Sci. 71(1), 45–57 (2013)
12) Kim EJ, et al. Exp Dermatol. 154, 625–33 (2005)
13) Maeda K et al. J Photochem Photobiol B. 47(2–3), 136–41 (1998)
14) Kim EH et al. J Dermatol Sci. 46, 111–116 (2007)
15) Kang HY, Ortonne JP. Ann Dermatol. 22, 373–378 (2010)
16) Hesegawa K, et al. J Dermatol. Oct 43(10), 1209-1213 (2016)
17) Aoki H, et al. Br J Dermatol. 156(6), 1214–23 (2007)
2-1
1) Kim, E. H., Kim, Y. C., Lee, E. S. & Kang, H. Y. The vascular characteristics of melasma. J Dermatol Sci 46(2), 111–116 (2007).
2) Regazzetti, C. et al. Endothelial Cells Promote Pigmentation through Endothelin Receptor B Activation. J Invest Dermatol 135(12), 3096–3104 (2015).
3) Adini, I. et al. Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Invest 124(1), 425–436 (2014).
4) Hasegawa, K. et al. Increased blood flow and vasculature in solar lentigo. J Dermatol 43(10), 1209–1213 (2016).
5) Renier, N., Wu, Z., Simon, D. J., Yang, J., Ariel, P., & Tessier-Lavigne, M. (2014). iDISCO: A simple, rapid method to immunolabel large tissue samples for volume imaging. Cell, 159, 896–910.
6) Unver, N., Freyschmidt-Paul, P., Horster, S., Wenck, H., Stab, F., Blatt, T. & Elsasser, H. P. (2006). Alterations in the epidermal-dermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin. The British Journal of Dermatology, 155, 119–128.
7) Aoki, H., Moro, O., Tagami, H., & Kishimoto, J. (2007). Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics. The British Journal of Dermatology, 156, 1214–1223.
8) Tsutsumi, M., Fukuda, M., Kumamoto, J., Goto, M., Denda, S., Yamasaki,K., Denda, M. (2016). Abnormal morphology of blood vessels in erythematous skin from atopic dermatitis patients. The American Journal of Dermatopathology, 38, 363–364.
2-2
1) Rees, J. L. The genetics of sun sensitivity in humans. Am J Hum Genet 75(5), 739–751 (2004).
2) Kovacs, D. et al. Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo. Br J Dermatol 163(5), 1020–1027 (2010).
3) Salducci, M. et al. Factors secreted by irradiated aged fibroblasts induce solar lentigo in pigmented reconstructed epidermis. Pigment Cell Melanoma Res 27(3), 502–504 (2014).
4) Kang, H. Y. et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol 154(6), 1094–1099 (2006).
5) Byun, J. W., Park, I. S., Choi, G. S. & Shin, J. Role of fibroblast-derived factors in the pathogenesis of melasma. Clin Exp Dermatol 41(6), 601–609 (2016).
6) Shin, J., Kim, J. H. & Kim, E. K. Repeated exposure of human fibroblasts to UVR induces secretion of stem cell factor and senescence. J Eur Acad Dermatol Venereol 26(12), 1577–1580 (2012).
7) Cario-André, M., Pain, C., Gauthier, Y., Casoli, V. & Taieb, A. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Melanoma Res 19(5), 434–442 (2006).
8) Kim, M., Han, J. H., Kim, J. H., Park, T. J. & Kang, H. Y. Secreted Frizzled-Related Protein 2 (sFRP2) Functions as a Melanogenic Stimulator; the Role of sFRP2 in UVInduced Hyperpigmentary Disorders. J Invest Dermatol 136(1), 236–44 (2016).
9) Kim, E. H., Kim, Y. C., Lee, E. S. & Kang, H. Y. The vascular characteristics of melasma. J Dermatol Sci 46(2), 111–116 (2007).
10) Kang, H. Y. et al. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol 19(8), e228–233 (2010).
11) Hasegawa, K. et al. Increased blood flow and vasculature in solar lentigo. J Dermatol 43(10), 1209–1213 (2016).
12) Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol 11(10), R106 (2010).
13) Heckmann, M., Eberlein-König, B., Wollenberg, A., Przybilla, B. & Plewig, G. Ultraviolet-A radiation induces adhesion molecule expression on human dermal microvascular endothelial cells. Br J Dermatol 131(3), 311–318 (1994).
14) Cauchard, J. H. et al. UVA-mediated down-regulation of MMP-2 and MT1-MMP coincides with impaired angiogenic phenotype of human dermal endothelial cells. Biochem Biophys Res Commun 345(2), 681–687 (2006).
15) Chung, K. Y., Chang, N. S., Park, Y. K. & Lee, K. H. Effect of ultraviolet light on the expression of adhesion molecules and T lymphocyte adhesion to human dermal microvascular endothelial cells. Yonsei Med J 43(2), 165–174 (2002).
16) Slominski, A. T. et al. Sensing the environment: regulation of local and global homeostasis by the skin’s neuroendocrine system. Adv Anat Embryol Cell Biol 212, 1– 115 (2012).
17) Slominski, A., Tobin, D. J., Shibahara, S. & Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84(4), 1155–1228 (2004).
18) Slominski, A. T. et al. Key role of CRF in the skin stress response system. Endocr Rev 34(6), 827–884 (2013).
19) Skobowiat, C., Dowdy, J. C., Sayre, R. M., Tuckey, R. C. & Slominski, A. Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab 301(3), E484–493 (2011).
20) Yamaguchi, Y. & Hearing, V. J. Physiological factors that regulate skin pigmentation. Biofactors 35(2), 193–199 (2009).
21) Tousoulis, D., Kampoli, A. M., Tentolouris, C., Papageorgiou, N. & Stefanadis, C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10(1), 193–199 (2009).
22) Lassalle, M. W. et al. Effects of melanogenesis-inducing nitric oxide and histamine on the production of eumelanin and pheomelanin in cultured human melanocytes. Pigment Cell Res 16(1), 81–84 (2003).
23) Hachiya, A., Kobayashi, A., Ohuchi, A., Takema, Y. & Imokawa, G. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultravioletB-induced pigmentation. J Invest Dermatol 116(4), 578–586 (2001).
24) Na, Y. J. et al. [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl) sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs. Biochem Pharmacol 74(5), 780–786 (2007).
25) Grichnik, J. M., Burch, J. A., Burchette, J. & Shea, C. R. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 111(2), 233–238 (1998).
2-3
1) Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomizedcontrolled clinical trial. J Cosmet Laser Ther 2012; 14: 150–4.
2) Budamakuntla L, Loganathan E, Suresh DH, et al. A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg 2013; 6: 139–43.
3) Lee JH, Park JG, Lim SH, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 2006; 32: 626–31.
4) Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol 2013; 27: 1035–9.
5) Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 2011; 64: 78–83.
6) Wu S, Shi H, Wu H, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg 2012; 36: 964–70.
7) Kal HB, Struikmans H, Gebbink MF, Voest EE. Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA. Strahlenther Onkol 2004; 180: 798–804.
8) Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol 2013; 12: 57–66.
9) Maeda K, Naganuma M. Topical trans-4 aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol, B 1998; 47: 136–41.
10)Kang HY, Hwang JS, Lee JY, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol 2006; 154: 1094–9.
11) Im S, Kim J, On WY, Kang WH. Increased expression of alpha-melanocytestimulating hormone in the lesional skin of melasma. Br J Dermatol 2002; 146:165– 7.
12) Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995; 105: 32–7.
13) Imokawa G, Kobayashi T, Miyagishi M, et al. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res 1997; 10: 218–28